We use our own and third party cookies in order to improve our performance, and to obtain anonymous statistics about the use of the website. By continuing to browse, you authorize their use. In order to change the preferences and to obtain further information, please refer to our cookies policy.




Laboratorios LETI has taken a majority stake in Univet, leader in Spain in Veterinary Dermatology, with a presence in Italy, France and Portugal.

Univet was born in 2001 (Barcelona) and is specialized in the diagnosis and treatment of skin diseases of pets. This includes the diagnosis and treatment of veterinary allergies, whose most common manifestation is in the skin.

The close collaboration between the two companies will allow the development of Univet, while facilitating the access of all our Business Units to the veterinary segment.

Both companies will work together on the development of numerous business opportunities and cooperation that have been identified, which are currently undergoing analysis and prioritization. As a first step, since last January the production plant in Tres Cantos is already producing allergy vaccines that sells Univet, thus supporting the business of LETI in allergy and the occupation of our plant.